A detailed history of Vanguard Group Inc transactions in Natera, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,044,743 shares of NTRA stock, worth $1.18 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,044,743
Previous 10,971,895 0.66%
Holding current value
$1.18 Billion
Previous $687 Million 46.98%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$59.21 - $92.9 $4.31 Million - $6.77 Million
72,848 Added 0.66%
11,044,743 $1.01 Billion
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $22.1 Million - $36.8 Million
588,147 Added 5.66%
10,971,895 $687 Million
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $2.52 Million - $3.63 Million
-58,102 Reduced 0.56%
10,383,748 $459 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $13.2 Million - $15.5 Million
280,485 Added 2.76%
10,441,850 $508 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $7.89 Million - $12.6 Million
215,851 Added 2.17%
10,161,365 $564 Million
Q4 2022

Feb 10, 2023

BUY
$34.17 - $47.91 $55.8 Million - $78.2 Million
1,632,930 Added 19.64%
9,945,514 $400 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $13.7 Million - $21.1 Million
371,740 Added 4.68%
8,312,584 $364 Million
Q2 2022

Aug 12, 2022

BUY
$28.13 - $44.54 $4.41 Million - $6.98 Million
156,662 Added 2.01%
7,940,844 $281 Million
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $53,696 - $161,745
-1,771 Reduced 0.02%
7,784,182 $317 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $5.22 Million - $7.2 Million
-60,511 Reduced 0.77%
7,785,953 $727 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $38.3 Million - $48.3 Million
382,199 Added 5.12%
7,846,464 $874 Million
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $642 Million - $894 Million
7,464,265 New
7,464,265 $847 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.